ST Pharm Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares ST Pharm Co Ltd with three other
pharmaceutical manufacturers in Asia:
Suven Life Sciences Limited
sales of 6.25 billion Indian Rupees [US$87.60 million]
of which 95%
was Intermediaries under Contract Research/M),
Morepen Laboratories Limited
(6.07 billion Indian Rupees [US$84.97 million]
of which 100%
was Pharmaceuticals), and
Astrazeneca Pharma India Ltd
based in India
(5.71 billion Indian Rupees [US$80.00 million]
ST Pharm Co Ltd reported sales of 97.74 billion Korean Won (US$86.79 million)
December of 2018.
decrease of 51.8%
versus 2017, when the company's sales were 202.80 billion Korean Won.